Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/4057

TDMS Study 05217-99 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                        T-BUTYLHYDROQUINONE


NTP Experiment-Test: 05217-99                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 04/07/95
Route: DOSED FEED                                                                                                 Time: 14:28:37


                                               05217/03 -VS- 05217/04 COMPARISON


       Facility:  SOUTHERN RESEARCH INSTITUTE

       Chemical CAS #:  1948-33-0

       Lock Date:  05/26/93

       Cage Range:  All

       Reasons For Removal:    25019 Moribund Sacrifice                25020 Natural Death
                               25021 Terminal Sacrifice

       Removal Date Range:     All

       Treatment Groups:       Include 001    UNTREATD CONTROL
                               Include 002    UNTREATD CONTROL
                               Include 005    RTD UNTRCONTROL
                               Include 006    RTD UNTRCONTROL



























a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          70           70                                                               
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                40           39                                                               
    Natural Death                                     10            3                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                10           18                                                               

  Animals Examined Microscopically                    60           60                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (58)         (58)                                                             
      Epithelium, Hyperplasia                                       1 (2%)                                                          
   Intestine Large, Colon                             (60)         (59)                                                             
      Parasite Metazoan                                6 (10%)      4 (7%)                                                          
   Intestine Large, Rectum                            (59)         (60)                                                             
      Edema                                            1 (2%)                                                                       
      Parasite Metazoan                                2 (3%)       5 (8%)                                                          
   Intestine Large, Cecum                             (60)         (60)                                                             
      Edema                                                         1 (2%)                                                          
      Parasite Metazoan                                2 (3%)       1 (2%)                                                          
   Intestine Small, Duodenum                          (59)         (59)                                                             
      Erosion                                                       1 (2%)                                                          
      Epithelium, Hyperplasia                                       1 (2%)                                                          
   Liver                                              (60)         (60)                                                             
      Angiectasis                                      1 (2%)                                                                       
      Basophilic Focus                                26 (43%)     26 (43%)                                                         
      Clear Cell Focus                                 2 (3%)       2 (3%)                                                          
      Degeneration, Cystic                             1 (2%)                                                                       
      Eosinophilic Focus                              10 (17%)      7 (12%)                                                         
      Hematopoietic Cell Proliferation                 1 (2%)       2 (3%)                                                          
      Hepatodiaphragmatic Nodule                      12 (20%)      2 (3%)                                                          
      Inflammation, Granulomatous                     12 (20%)      7 (12%)                                                         
      Inflammation, Subacute                                        1 (2%)                                                          
      Mixed Cell Focus                                 2 (3%)       8 (13%)                                                         
      Necrosis, Focal                                  6 (10%)      7 (12%)                                                         
      Bile Duct, Hyperplasia                          17 (28%)     23 (38%)                                                         
      Hepatocyte, Vacuolization Cytoplasmic           14 (23%)      7 (12%)                                                         
      Kupffer Cell, Pigmentation                      12 (20%)     14 (23%)                                                         
   Mesentery                                          (11)         (8)                                                              
      Accessory Spleen                                 1 (9%)       2 (25%)                                                         
      Fat, Necrosis                                    9 (82%)      5 (63%)                                                         
   Pancreas                                           (60)         (60)                                                             
      Atrophy                                         20 (33%)     15 (25%)                                                         
      Metaplasia, Hepatocyte                           1 (2%)                                                                       

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Acinus, Cytoplasmic Alteration                                1 (2%)                                                          
   Salivary Glands                                    (60)         (60)                                                             
      Atrophy                                          2 (3%)                                                                       
   Stomach, Forestomach                               (60)         (59)                                                             
      Edema                                            4 (7%)       1 (2%)                                                          
      Erosion                                          1 (2%)       1 (2%)                                                          
      Ulcer                                            2 (3%)       4 (7%)                                                          
      Epithelium, Hyperplasia                                       5 (8%)                                                          
      Mucosa, Hyperplasia                              5 (8%)                                                                       
   Stomach, Glandular                                 (60)         (59)                                                             
      Edema                                            1 (2%)       1 (2%)                                                          
      Erosion                                          3 (5%)       1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Ulcer                                            2 (3%)       2 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)                                                             
      Cardiomyopathy                                  28 (47%)     29 (48%)                                                         
      Mineralization                                                1 (2%)                                                          
      Thrombosis                                       3 (5%)       2 (3%)                                                          
      Schwann Cell, Hyperplasia                                     1 (2%)                                                          
      Valve, Inflammation, Chronic                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)                                                             
      Accessory Adrenal Cortical Nodule               11 (18%)      9 (15%)                                                         
      Atrophy                                          1 (2%)                                                                       
      Degeneration, Fatty                              9 (15%)     11 (18%)                                                         
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Hyperplasia, Diffuse                             3 (5%)       1 (2%)                                                          
      Hyperplasia, Focal                               3 (5%)       7 (12%)                                                         
      Hypertrophy, Focal                               9 (15%)      5 (8%)                                                          
      Necrosis                                                      1 (2%)                                                          
   Adrenal Medulla                                    (60)         (57)                                                             
      Hyperplasia                                      5 (8%)       5 (9%)                                                          
   Islets, Pancreatic                                 (60)         (60)                                                             
      Hyperplasia                                      1 (2%)                                                                       
   Parathyroid Gland                                  (52)         (55)                                                             
      Hyperplasia                                      1 (2%)       2 (4%)                                                          
   Pituitary Gland                                    (60)         (59)                                                             
      Pars Distalis, Angiectasis                       8 (13%)      2 (3%)                                                          
      Pars Distalis, Cyst                             14 (23%)      9 (15%)                                                         
      Pars Distalis, Hyperplasia, Focal                9 (15%)     11 (19%)                                                         

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Intermedia, Angiectasis                                  2 (3%)                                                          
      Pars Intermedia, Cyst                            2 (3%)       4 (7%)                                                          
   Thyroid Gland                                      (60)         (60)                                                             
      Ultimobranchial Cyst                             2 (3%)       2 (3%)                                                          
      C-Cell, Hyperplasia                              8 (13%)      4 (7%)                                                          
      Follicle, Cyst                                   1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (58)         (59)                                                             
      Cyst                                             2 (3%)       5 (8%)                                                          
      Cyst, Multiple                                   1 (2%)                                                                       
      Hyperplasia                                      3 (5%)       5 (8%)                                                          
      Inflammation, Chronic                            2 (3%)       3 (5%)                                                          
      Inflammation, Suppurative                        2 (3%)       2 (3%)                                                          
   Ovary                                              (60)         (60)                                                             
      Angiectasis                                                   2 (3%)                                                          
      Cyst                                            17 (28%)      6 (10%)                                                         
   Uterus                                             (60)         (60)                                                             
      Hydrometra                                       3 (5%)       4 (7%)                                                          
      Hyperplasia, Cystic                              4 (7%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (60)                                                             
      Depletion Cellular                               1 (2%)                                                                       
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Myelofibrosis                                    2 (3%)       1 (2%)                                                          
   Lymph Node                                         (20)         (19)                                                             
      Iliac, Ectasia                                                1 (5%)                                                          
      Mediastinal, Ectasia                             1 (5%)                                                                       
      Mediastinal, Hemorrhage                          3 (15%)                                                                      
      Mediastinal, Hyperplasia, Lymphoid               1 (5%)                                                                       
      Mediastinal, Pigmentation                       14 (70%)      8 (42%)                                                         
      Pancreatic, Ectasia                                           1 (5%)                                                          
      Pancreatic, Pigmentation                         1 (5%)       2 (11%)                                                         
      Renal, Pigmentation                              1 (5%)       6 (32%)                                                         
   Lymph Node, Mandibular                             (59)         (60)                                                             
      Ectasia                                          2 (3%)       3 (5%)                                                          

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hemorrhage                                       3 (5%)       5 (8%)                                                          
      Hyperplasia, Lymphoid                           13 (22%)      9 (15%)                                                         
      Hyperplasia, Plasma Cell                         1 (2%)       1 (2%)                                                          
      Pigmentation                                    20 (34%)     22 (37%)                                                         
   Lymph Node, Mesenteric                             (58)         (59)                                                             
      Ectasia                                          2 (3%)       1 (2%)                                                          
      Hemorrhage                                                    2 (3%)                                                          
      Hyperplasia, Lymphoid                            2 (3%)       1 (2%)                                                          
   Spleen                                             (60)         (60)                                                             
      Fibrosis                                         3 (5%)       4 (7%)                                                          
      Hematopoietic Cell Proliferation                15 (25%)      9 (15%)                                                         
      Necrosis                                                      1 (2%)                                                          
      Pigmentation, Hemosiderin                       24 (40%)     30 (50%)                                                         
      Lymphoid Follicle, Atrophy                       1 (2%)                                                                       
      Red Pulp, Atrophy                                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (60)         (60)                                                             
      Dilatation                                      37 (62%)     51 (85%)                                                         
      Galactocele                                      5 (8%)       1 (2%)                                                          
      Hyperplasia                                     12 (20%)      3 (5%)                                                          
   Skin                                               (60)         (60)                                                             
      Cyst Epithelial Inclusion                        1 (2%)                                                                       
      Hyperkeratosis                                   1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)                                                                       
      Ulcer                                                         1 (2%)                                                          
      Epidermis, Hyperplasia                           1 (2%)       1 (2%)                                                          
      Subcutaneous Tissue, Edema                                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)         (60)                                                             
      Fibrous Osteodystrophy                                        2 (3%)                                                          
      Cranium, Osteopetrosis                           8 (13%)      3 (5%)                                                          
      Femur, Osteopetrosis                             9 (15%)      3 (5%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)                                                             
      Atrophy                                         19 (32%)     17 (28%)                                                         
      Hemorrhage                                                    1 (2%)                                                          
      Hydrocephalus                                    4 (7%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)                                                             
      Congestion                                       1 (2%)                                                                       
      Edema                                                         1 (2%)                                                          
      Foreign Body                                                  1 (2%)                                                          
      Hemorrhage                                       2 (3%)       2 (3%)                                                          
      Infiltration Cellular, Histiocyte               28 (47%)     33 (55%)                                                         
      Inflammation, Subacute                           3 (5%)       1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Thrombosis                                       1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 4 (7%)       3 (5%)                                                          
   Nose                                               (60)         (60)                                                             
      Foreign Body                                     3 (5%)       1 (2%)                                                          
      Inflammation, Suppurative                        5 (8%)       3 (5%)                                                          
      Goblet Cell, Hyperplasia                        10 (17%)      7 (12%)                                                         
      Mucosa, Hyperplasia                              5 (8%)       4 (7%)                                                          
      Mucosa, Metaplasia, Squamous                     3 (5%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (1)          (2)                                                              
      Inflammation, Chronic                                         1 (50%)                                                         
   Eye                                                (4)                                                                           
      Cataract                                         3 (75%)                                                                      
      Hemorrhage                                       1 (25%)                                                                      
      Retina, Degeneration                             4 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)                                                             
      Glomerulosclerosis                                            1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Suppurative                        2 (3%)                                                                       
      Mineralization                                  57 (95%)     59 (98%)                                                         
      Nephropathy                                     37 (62%)     38 (63%)                                                         
      Renal Tubule, Atrophy                            1 (2%)       1 (2%)                                                          
      Renal Tubule, Cytoplasmic Alteration             5 (8%)       5 (8%)                                                          
      Renal Tubule, Dilatation                                      2 (3%)                                                          
      Renal Tubule, Necrosis                           2 (3%)       1 (2%)                                                          
      Renal Tubule, Pigmentation                      15 (25%)     17 (28%)                                                         
      Transitional Epithelium, Hyperplasia             2 (3%)       5 (8%)                                                          
   Urinary Bladder                                    (59)         (60)                                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          70           70                                                               
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                48           41                                                               
    Natural Death                                      4            6                                                               
  Survivors                                                                                                                         
    Moribund Sacrifice                                              2                                                               
    Natural Death                                                   1                                                               
    Terminal Sacrifice                                 8           10                                                               

  Animals Examined Microscopically                    60           60                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (58)         (60)                                                             
      Parasite Metazoan                                7 (12%)      7 (12%)                                                         
   Intestine Large, Rectum                            (59)         (59)                                                             
      Edema                                            2 (3%)                                                                       
      Parasite Metazoan                                5 (8%)       4 (7%)                                                          
   Intestine Large, Cecum                             (60)         (60)                                                             
      Edema                                            3 (5%)       3 (5%)                                                          
      Parasite Metazoan                                1 (2%)                                                                       
   Intestine Small, Duodenum                          (60)         (60)                                                             
      Ulcer                                                         3 (5%)                                                          
      Epithelium, Hyperplasia                          2 (3%)                                                                       
   Intestine Small, Jejunum                           (60)         (60)                                                             
      Epithelium, Hyperplasia                          1 (2%)                                                                       
   Liver                                              (60)         (60)                                                             
      Angiectasis                                     10 (17%)      5 (8%)                                                          
      Basophilic Focus                                 7 (12%)      5 (8%)                                                          
      Clear Cell Focus                                 1 (2%)                                                                       
      Degeneration, Cystic                            23 (38%)      6 (10%)                                                         
      Eosinophilic Focus                              10 (17%)      6 (10%)                                                         
      Eosinophilic Focus, Multiple                     1 (2%)                                                                       
      Fibrosis                                         1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)                                                          
      Hepatodiaphragmatic Nodule                       7 (12%)      2 (3%)                                                          
      Mixed Cell Focus                                 2 (3%)                                                                       
      Necrosis, Focal                                  8 (13%)      7 (12%)                                                         
      Thrombosis                                       1 (2%)                                                                       
      Bile Duct, Cyst                                  2 (3%)                                                                       
      Bile Duct, Hyperplasia                          52 (87%)     45 (75%)                                                         
      Centrilobular, Necrosis                          2 (3%)                                                                       
      Hepatocyte, Vacuolization Cytoplasmic            6 (10%)      2 (3%)                                                          
      Kupffer Cell, Hyperplasia                                     1 (2%)                                                          
      Kupffer Cell, Pigmentation                      11 (18%)     19 (32%)                                                         

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    8                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Mesentery                                          (20)         (8)                                                              
      Accessory Spleen                                 1 (5%)       2 (25%)                                                         
      Fat, Necrosis                                   16 (80%)      4 (50%)                                                         
   Pancreas                                           (60)         (58)                                                             
      Atrophy                                         15 (25%)     21 (36%)                                                         
      Acinus, Cytoplasmic Alteration                   3 (5%)                                                                       
      Acinus, Hyperplasia, Focal                       2 (3%)                                                                       
   Salivary Glands                                    (60)         (60)                                                             
      Atrophy                                                       1 (2%)                                                          
   Stomach, Forestomach                               (60)         (60)                                                             
      Edema                                            9 (15%)                                                                      
      Hyperplasia                                      8 (13%)      5 (8%)                                                          
      Ulcer                                            8 (13%)      1 (2%)                                                          
      Mucosa, Hyperplasia                              1 (2%)                                                                       
   Stomach, Glandular                                 (60)         (60)                                                             
      Edema                                            1 (2%)       1 (2%)                                                          
      Erosion                                          1 (2%)       1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Ulcer                                            3 (5%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (60)         (60)                                                             
      Hypertrophy                                      1 (2%)       1 (2%)                                                          
      Inflammation, Subacute                           1 (2%)       1 (2%)                                                          
      Thrombosis                                                    1 (2%)                                                          
   Heart                                              (60)         (60)                                                             
      Cardiomyopathy                                  40 (67%)     34 (57%)                                                         
      Necrosis                                         1 (2%)                                                                       
      Thrombosis                                       6 (10%)      5 (8%)                                                          
      Endocardium, Hyperplasia                         1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)                                                             
      Accessory Adrenal Cortical Nodule               17 (28%)     13 (22%)                                                         
      Angiectasis                                                   1 (2%)                                                          
      Degeneration, Fatty                              9 (15%)     13 (22%)                                                         
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Hyperplasia, Diffuse                                          1 (2%)                                                          
      Hyperplasia, Focal                               4 (7%)       2 (3%)                                                          
      Hypertrophy, Focal                               6 (10%)      5 (8%)                                                          
      Necrosis                                         1 (2%)                                                                       
   Adrenal Medulla                                    (60)         (59)                                                             
      Hyperplasia                                     26 (43%)     18 (31%)                                                         

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    9                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Islets, Pancreatic                                 (60)         (58)                                                             
      Hyperplasia                                      3 (5%)       2 (3%)                                                          
   Parathyroid Gland                                  (55)         (56)                                                             
      Hyperplasia                                      6 (11%)                                                                      
   Pituitary Gland                                    (60)         (57)                                                             
      Pars Distalis, Angiectasis                       4 (7%)       3 (5%)                                                          
      Pars Distalis, Cyst                              6 (10%)      7 (12%)                                                         
      Pars Distalis, Cyst, Hemorrhagic                 1 (2%)                                                                       
      Pars Distalis, Hyperplasia, Focal               10 (17%)     14 (25%)                                                         
      Pars Intermedia, Cyst                            1 (2%)       2 (4%)                                                          
   Thyroid Gland                                      (60)         (60)                                                             
      Ultimobranchial Cyst                             1 (2%)                                                                       
      C-Cell, Hyperplasia                              9 (15%)      5 (8%)                                                          
      Follicle, Cyst                                   1 (2%)       2 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (60)         (60)                                                             
      Atypia Cellular                                 27 (45%)     25 (42%)                                                         
   Preputial Gland                                    (60)         (60)                                                             
      Cyst                                             3 (5%)       3 (5%)                                                          
      Hyperplasia                                      3 (5%)       1 (2%)                                                          
      Inflammation, Chronic                           26 (43%)      9 (15%)                                                         
      Inflammation, Suppurative                        3 (5%)       1 (2%)                                                          
   Prostate                                           (60)         (60)                                                             
      Cyst                                             1 (2%)                                                                       
      Fibrosis                                         3 (5%)                                                                       
      Inflammation, Chronic                            5 (8%)                                                                       
      Inflammation, Suppurative                       36 (60%)     28 (47%)                                                         
      Epithelium, Hyperplasia                         11 (18%)      3 (5%)                                                          
   Testes                                             (60)         (60)                                                             
      Atrophy                                                       2 (3%)                                                          
      Interstitial Cell, Hyperplasia                   4 (7%)       3 (5%)                                                          
      Seminiferous Tubule, Atrophy                     7 (12%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   10                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (60)                                                             
      Hyperplasia                                      6 (10%)      2 (3%)                                                          
      Myelofibrosis                                    4 (7%)       8 (13%)                                                         
   Lymph Node                                         (33)         (36)                                                             
      Iliac, Hemorrhage                                1 (3%)                                                                       
      Inguinal, Hyperplasia, Lymphoid                  2 (6%)                                                                       
      Mediastinal, Hemorrhage                          3 (9%)       2 (6%)                                                          
      Mediastinal, Hyperplasia, Lymphoid               1 (3%)                                                                       
      Mediastinal, Pigmentation                       13 (39%)     19 (53%)                                                         
      Pancreatic, Pigmentation                         9 (27%)      8 (22%)                                                         
      Renal, Hemorrhage                                1 (3%)       1 (3%)                                                          
      Renal, Pigmentation                              8 (24%)      7 (19%)                                                         
   Lymph Node, Mandibular                             (60)         (60)                                                             
      Ectasia                                          3 (5%)       2 (3%)                                                          
      Hemorrhage                                       2 (3%)       1 (2%)                                                          
      Hyperplasia, Lymphoid                           11 (18%)      5 (8%)                                                          
      Hyperplasia, Plasma Cell                                      1 (2%)                                                          
      Pigmentation                                     6 (10%)     13 (22%)                                                         
   Lymph Node, Mesenteric                             (60)         (60)                                                             
      Ectasia                                          7 (12%)      2 (3%)                                                          
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Hyperplasia, Lymphoid                            3 (5%)       1 (2%)                                                          
   Spleen                                             (60)         (60)                                                             
      Congestion                                       1 (2%)                                                                       
      Fibrosis                                        21 (35%)     13 (22%)                                                         
      Hematopoietic Cell Proliferation                 7 (12%)      2 (3%)                                                          
      Metaplasia, Lipocyte                             1 (2%)                                                                       
      Necrosis                                         2 (3%)       2 (3%)                                                          
      Pigmentation, Hemosiderin                       13 (22%)      3 (5%)                                                          
      Lymphoid Follicle, Atrophy                       1 (2%)       2 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (57)         (58)                                                             
      Dilatation                                      23 (40%)     16 (28%)                                                         
      Galactocele                                      5 (9%)                                                                       
      Hyperplasia                                      7 (12%)      7 (12%)                                                         
   Skin                                               (60)         (60)                                                             
      Cyst Epithelial Inclusion                        2 (3%)                                                                       
      Hyperkeratosis                                                1 (2%)                                                          
      Hyperplasia                                                   1 (2%)                                                          
      Epidermis, Hyperplasia                           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   11                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)         (60)                                                             
      Fibrous Osteodystrophy                           6 (10%)                                                                      
      Hyperostosis                                     1 (2%)                                                                       
      Femur, Osteopetrosis                             1 (2%)       2 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)                                                             
      Atrophy                                         12 (20%)      3 (5%)                                                          
      Hemorrhage                                       2 (3%)       1 (2%)                                                          
      Hydrocephalus                                    4 (7%)       1 (2%)                                                          
      Necrosis                                         1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)                                                             
      Congestion                                       2 (3%)       1 (2%)                                                          
      Edema                                            1 (2%)       3 (5%)                                                          
      Hemorrhage                                       3 (5%)       4 (7%)                                                          
      Infiltration Cellular, Histiocyte               19 (32%)     14 (23%)                                                         
      Metaplasia, Osseous                              1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 4 (7%)       5 (8%)                                                          
   Nose                                               (60)         (60)                                                             
      Foreign Body                                     6 (10%)      3 (5%)                                                          
      Inflammation                                                  1 (2%)                                                          
      Inflammation, Suppurative                       17 (28%)      5 (8%)                                                          
      Goblet Cell, Hyperplasia                         5 (8%)       8 (13%)                                                         
      Mucosa, Hyperplasia                             14 (23%)      8 (13%)                                                         
      Mucosa, Metaplasia, Squamous                     8 (13%)      7 (12%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (4)          (1)                                                              
      Atrophy                                          2 (50%)                                                                      
      Cataract                                         1 (25%)      1 (100%)                                                        
      Retina, Degeneration                             1 (25%)      1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   12                                                              
NTP Experiment-Test: 05217-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        T-BUTYLHYDROQUINONE                                    Date: 04/07/95  
Route: DOSED FEED                                                                                                 Time: 14:28:37  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     UNTREATD     RTD UNTR                                                            
                                                    CONTROL     CONTROL                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)                                                             
      Cyst                                             2 (3%)       2 (3%)                                                          
      Infiltration Cellular, Lipocyte                               1 (2%)                                                          
      Inflammation, Suppurative                        9 (15%)                                                                      
      Mineralization                                  12 (20%)      4 (7%)                                                          
      Nephropathy                                     60 (100%)    51 (85%)                                                         
      Renal Tubule, Accumulation, Hyaline Droplet      1 (2%)       1 (2%)                                                          
      Renal Tubule, Atrophy                                         1 (2%)                                                          
      Renal Tubule, Necrosis                           3 (5%)       3 (5%)                                                          
      Renal Tubule, Pigmentation                      18 (30%)     17 (28%)                                                         
      Transitional Epithelium, Hyperplasia            13 (22%)      1 (2%)                                                          
   Urinary Bladder                                    (60)         (60)                                                             
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia             2 (3%)       1 (2%)                                                          
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   13                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------